RLAY — Relay Therapeutics Share News
0.000.00%
Last trade - 00:00- $3.19bn
- $2.55bn
- $15.36m
U.S. STOCKS ON THE MOVE- Intuit, Deere, Advance Auto Parts
U.S. STOCKS ON THE MOVE-Keysight Technologies, Relay Therapeutics, Ralph Lauren
Relay Therapeutics gains after $275 mln equity raise
Brief: Relay Therapeutics Announces Pricing Of Public Offering Of Common Stock
Relay jumps on promising vascular disorder drug data
U.S. RESEARCH ROUNDUP- CAVA Group, Eagle Materials, Vertiv Holdings
Relay Therapeutics drops on $175 mln stock offering
U.S. STOCKS ON THE MOVE- Hims & Hers Health, Driven Brands, Onto Innovation
U.S. STOCKS ON THE MOVE-T1 Energy, Home Depot, X-Energy
U.S. STOCKS ON THE MOVE-Nvidia, SiTime Corp, Hoth Therapeutics
U.S. STOCKS ON THE MOVE-Alphabet, Relay Therapeutics, Amer Sports
Relay Therapeutics rises after vascular disorder drug shows promise in study
Relay's treatment shown to shrink vascular malformations in mid-stage trial (updated)
Brief: Relay Therapeutics Announces Initial Clinical Data Demonstrating That Zovegalisib Has Potential For Differentiated Safety And Efficacy In Patients With PIK3CA-Driven Vascular Anomalies
Relay's treatment shown to shrink vascular malformations in mid-stage trial
Brief: Relay Therapeutics Q1 Net Income USD -73.291 Million Vs. IBES Estimate USD -65 Million
U.S. RESEARCH ROUNDUP-Commvault Systems, Domino's Pizza, Organon & Co
Relay Therapeutics beats Q4 revenue expectations
Brief: Relay Therapeutics Q4 Net Income USD -54.889 Million Vs. IBES Estimate USD -68.1 Million